Phreesia, Inc. PHR
Set alert
As of Nov 2, 10:12 AM ET
- YTD
- -26.33%
- 1 year
- -44.94%
- Open
- 12.45
- Prev close
- 12.44
- Mkt cap
- 773.40M
- Vol
- 50.68K
- Avg vol
- 733.79K
- EPS
- 0.17
- P/E
- 73.29
- Div yield
- 0.00%
More statistics
- Low
- 12.19
- High
- 12.52
- Forward P/E
- -25.76
- Beta
- 0.64
- Short ratio
- 7.35
- Inst. own
- 104.22%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 22.08
- 200-d avg
- 25.25
- 1y target
- 32.47
2Y chart
Events in this range
- Sep 4, 2025Earnings: 0.01; estimate —; surprise 114.29%
- Dec 8, 2025Earnings: 0.1; estimate —; surprise —%
- Dec 8, 2025Rating: Needham · Buy → Buy
- Dec 9, 2025Rating: Barclays · — → Overweight
- Dec 9, 2025Rating: JP Morgan · Overweight → Overweight
- Dec 9, 2025Rating: Canaccord Genuity · Buy → Buy
- Dec 9, 2025Rating: Needham · Buy → Buy
- Dec 9, 2025Rating: Citigroup · Buy → Buy
Signals (85)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 19, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 18, 2026 | 2 months ago |
| RSI: Overbought | Aug 13, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| SMA: Bullish | May 29, 2026 | 5 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 16, 2026 | 6 months ago |
| RSI: Oversold | Apr 9, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 31, 2026 | 7 months ago |
| RSI: Oversold | Mar 31, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 17, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 16, 2026 | 7 months ago |
| RSI: Oversold | Mar 12, 2026 | 7 months ago |
| RSI: Oversold | Feb 23, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| RSI: Oversold | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 21, 2026 | 9 months ago |
| MACD: Buy Signal | Dec 23, 2025 | 10 months ago |
| RSI: Oversold | Dec 16, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 9, 2025 | 10 months ago |
| RSI: Oversold | Dec 9, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 2, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| RSI: Oversold | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 7, 2025 | 12 months ago |
| MACD: Buy Signal | Oct 6, 2025 | 1 year ago |
| RSI: Oversold | Sep 17, 2025 | 1 year ago |
| RSI: Oversold | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 5, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 5, 2025 | 1 year ago |
| RSI: Overbought | Aug 27, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Aug 8, 2025 | 1 year ago |
| SMA: Bearish | Aug 7, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | Jul 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| SMA: Bullish | Jun 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| MACD: Sell Signal | May 21, 2025 | 1 year ago |
| SMA: Bullish | May 8, 2025 | 1 year ago |
| SMA: Bearish | May 5, 2025 | 1 year ago |
| SMA: Bullish | May 2, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 24, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 26, 2025 | 1 year ago |
| SMA: Bullish | Mar 18, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| RSI: Oversold | Mar 7, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 7, 2025 | 1 year ago |
| RSI: Overbought | Jan 7, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 31, 2024 | 1 year ago |
| RSI: Overbought | Dec 10, 2024 | 1 year ago |
Key statistics
- Market cap
- 925.98M
- Enterprise value
- 788.45M
- Trailing P/E
- 0.00
- Forward P/E
- -25.76
- PEG ratio
- 0.00
- Price / sales
- 2.06
- Price / book
- 3.10
- EPS (TTM)
- -0.42
- Beta
- 0.64
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -5.35%
- Revenue (TTM)
- 449.67M
- Revenue growth
- 45.70%
- Free cash flow
- 36.91M
- Total cash
- 439.85M
- Total debt
- 12.64M
- Return on equity
- -8.76%
- Shares outstanding
- 59.91M
- Short % of float
- 5.99%
- 50-day average
- 22.08
- 200-day average
- 25.25
Analyst view
Consensus: strong buy
- Target (low)
- 26.00
- Target (mean)
- 32.47
- Target (high)
- 36.00
- Strong buy6
- Buy12
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.36.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Dec 8, 2025 | Oct 1, 2025 | — | 0.10 | — | — |
| Sep 4, 2025 | Jul 1, 2025 | — | 0.01 | +0.08 | +114.29% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 9, 2025 | Citigroup | main | Buy | Buy |
| Dec 9, 2025 | Needham | reit | Buy | Buy |
| Dec 9, 2025 | Canaccord Genuity | main | Buy | Buy |
| Dec 9, 2025 | JP Morgan | main | Overweight | Overweight |
| Dec 9, 2025 | Barclays | init | — | Overweight |
| Dec 8, 2025 | Needham | reit | Buy | Buy |
About Phreesia, Inc.
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers an appointment scheduling system for online appointments, reminders, and referral tracking and management; registration solutions to automate patient self-registration; revenue cycle solutions that provide insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network solutions to deliver clinically relevant content to patients. It deploys its platform in a range of modalities, including Phreesia Mobile, a patients' mobile device; PhreesiaPads, a self-service intake tablets; Phreesia Dashboard, a web-based dashboard for healthcare services clients; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare services clients, including single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies, as well as government entities and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- phreesia.com
News
- Phreesia: Q3 Must Prove That Growth Can Drive Higher Profitability
- Barclays Maintains Equal-Weight on Phreesia, Raises Price Target to $11
- Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
- DA Davidson Maintains Buy on Phreesia, Lowers Price Target to $13
- Baird Maintains Neutral on Phreesia, Raises Price Target to $11
- Phreesia Files Shelf Prospectus For Offering; Size Not Disclosed
- These Analysts Revise Their Forecasts On Phreesia After Q2 Results
- Wells Fargo Maintains Equal-Weight on Phreesia, Raises Price Target to $10
- Transcript: Phreesia Q2 2027 Earnings Conference Call
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
Your note
Sign in to keep a note on PHR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAHILL EDWARD L | Director | Stock Award(Grant) | Oct 30, 2025 | 63,784 |
| GANDHI BALAJI | Chief Financial Officer | Sale | Oct 16, 2025 | 98,240 |
| GOLDSTEIN LAINIE | Director | Stock Award(Grant) | Oct 30, 2025 | 49,366 |
| HOFFMAN ALLISON C | General Counsel | Sale | Oct 16, 2025 | 135,737 |
| HUI YVONNE | Officer | Sale | Oct 14, 2025 | 30,336 |
| INDIG CHAIM EDWARDS | Chief Executive Officer | Sale | Oct 16, 2025 | 1,507,610 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 9.52% | 5,704,786 | 88.17M | Sep 29, 2025 |
| Blackrock Inc. | 9.50% | 5,692,736 | 87.98M | Sep 29, 2025 |
| FMR, LLC | 6.54% | 3,919,084 | 60.57M | Sep 29, 2025 |
| Greenhouse Funds, LLLP | 6.48% | 3,882,527 | 60.00M | Sep 29, 2025 |
| Capital International Investors | 5.23% | 3,134,872 | 48.45M | Sep 29, 2025 |
| Champlain Investment Partners, LLC | 4.47% | 2,678,825 | 41.40M | Sep 29, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 5.23% | 3,134,872 | 48.45M | Sep 29, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.93% | 1,753,748 | 27.10M | Sep 29, 2025 |
| iShares Trust-iShares Russell 2000 ETF | 2.38% | 1,427,488 | 22.06M | Sep 29, 2025 |
| Franklin Strategic Series-FRANKLIN SMALL CAP GROWTH FUND | 2.13% | 1,278,706 | 19.76M | Jul 30, 2025 |
| Old Westbury Funds Inc-Old Westbury Small & Mid Cap Strategies Fund | 1.86% | 1,115,063 | 17.23M | Jul 30, 2025 |
| Fidelity Select PORT.s-Select Medical Technology and Devices PORT. | 1.80% | 1,080,000 | 16.69M | Sep 29, 2025 |